Key contribution of CPEB4-mediated translational control to cancer progression

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Nature Medicine

• Publication date

  2011-12-04

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/nm.2540PMID 22138752
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Life is translation

  2014cited by this paper
• The hallmarks of cancer

  2012cited by this paper
• Translational control in cancer

  2010cited by this paper
• Meiosis requires a translational positive loop where CPEB1 ensues its replacement by CPEB4

  2010cited by this paper
• Mechanisms governing the control of mRNA translation

  2010cited by this paper
• Regulation of cell signalling by uPAR

  2010cited by this paper
• Ectopic Expression of Germline Genes Drives Malignant Brain Tumor Growth in Drosophila

  2010cited by this paper
• MYC as a regulator of ribosome biogenesis and protein synthesis

  2010cited by this paper
• Mitotic cell-cycle progression is regulated by CPEB1 and CPEB4-dependent translational control

  2010cited by this paper
• The urokinase receptor: Focused cell surface proteolysis, cell adhesion and signaling

  2010cited by this paper
• Galectin-1 is a novel functional receptor for tissue plasminogen activator in pancreatic cancer.

  2009cited by this paper
• Identification of CD15 as a marker for tumor-propagating cells in a mouse model of medulloblastoma.

  2009cited by this paper
• Regulation of translation initiation in eukaryotes: mechanisms and biological targets.

  2009cited by this paper
• The urokinase plasminogen activator system: a target for anti-cancer therapy.

  2009cited by this paper
• Urokinase-type plasminogen activator receptor transcriptionally controlled adenoviruses eradicate pancreatic tumors and liver metastasis in mouse models.

  2009cited by this paper
• Alternative Splicing in Lung Cancer

  2009cited by this paper
• Increased MicroRNA Activity in Human Cancers

  2009cited by this paper
• Reprogramming of 3′ Untranslated Regions of mRNAs by Alternative Polyadenylation in Generation of Pluripotent Stem Cells from Different Cell Types

  2009cited by this paper
• Widespread shortening of 3'UTRs by alternative cleavage and polyadenylation activates oncogenes in cancer cells.

  2009cited by this paper
• DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancer.

  2009cited by this paper
• Expression of CPEB, GAPDH and U6snRNA in cervical and ovarian tissue during cancer development

  2009cited by this paper
• Translational control from head to tail.

  2009cited by this paper
• Increasing the relative expression of endogenous non-coding Steroid Receptor RNA Activator (SRA) in human breast cancer cells using modified oligonucleotides

  2009cited by this paper
• A combinatorial code for CPE-mediated translational control.

  2008cited by this paper
• Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses

  2008cited by this paper
• A deadenylation negative feedback mechanism governs meiotic metaphase arrest

  2008cited by this paper
• CPEB regulation of human cellular senescence, energy metabolism, and p53 mRNA translation.

  2008cited by this paper
• Eukaryotic initiation factor 6 is rate-limiting in translation, growth and transformation

  2008cited by this paper
• The splicing-factor oncoprotein SF2/ASF activates mTORC1

  2008cited by this paper
• Spindle-localized CPE-mediated translation controls meiotic chromosome segregation

  2008cited by this paper
• Cross-species comparison of human and mouse intestinal polyps reveals conserved mechanisms in adenomatous polyposis coli (APC)-driven tumorigenesis.

  2008cited by this paper
• An Integrated Genomic Analysis of Human Glioblastoma Multiforme

  2008cited by this paper
• The gene encoding the splicing factor SF2/ASF is a proto-oncogene

  2007cited by this paper
• CPEB: a life in translation.

  2007cited by this paper
• A five-gene signature and clinical outcome in non-small-cell lung cancer.

  2007cited by this paper
• Disrupting the Pairing Between let-7 and Hmga2 Enhances Oncogenic Transformation

  2007cited by this paper
• Parallels between global transcriptional programs of polarizing Caco-2 intestinal epithelial cells in vitro and gene expression programs in normal colon and colon cancer.

  2007cited by this paper
• The Plasminogen Activator System and Cancer

  2007cited by this paper
• The tumor suppressor microRNA let-7 represses the HMGA2 oncogene.

  2007cited by this paper
• The connection between splicing and cancer

  2006cited by this paper
• Control of cellular senescence by CPEB.

  2006cited by this paper
• Alternative splicing and differential gene expression in colon cancer detected by a whole genome exon array

  2006cited by this paper
• CPEB3 and CPEB4 in neurons: analysis of RNA‐binding specificity and translational control of AMPA receptor GluR2 mRNA

  2006cited by this paper
• The translation factor eIF-4E promotes tumor formation and cooperates with c-Myc in lymphomagenesis

  2004cited by this paper
• Tissue plasminogen activator in murine exocrine pancreas cancer: selective expression in ductal tumors and contribution to cancer progression.

  2004cited by this paper
• Analysis of gene expression in cancer cell lines identifies candidate markers for pancreatic tumorigenesis and metastasis

  2004cited by this paper
• Rapid, Activity-Induced Increase in Tissue Plasminogen Activator Is Mediated by Metabotropic Glutamate Receptor-Dependent mRNA Translation

  2004cited by this paper
• Highly expressed genes in pancreatic ductal adenocarcinomas: a comprehensive characterization and comparison of the transcription profiles obtained from three major technologies.

  2003cited by this paper
• Relationships and differentially expressed genes among pancreatic cancers examined by large-scale serial analysis of gene expression.

  2002cited by this paper
• Tissue plasminogen activator is required for the growth, invasion, and angiogenesis of pancreatic tumor cells.

  2002cited by this paper
• MEANS TO AN END

  2002cited by this paper
• Translational control by CPEB: a means to the end

  2001cited by this paper
• Urokinase receptor and fibronectin regulate the ERK(MAPK) to p38(MAPK) activity ratios that determine carcinoma cell proliferation or dormancy in vivo.

  2001cited by this paper
• The plasminogen activator system in pancreas cancer: role of t-PA in the invasive potential in vitro

  1998cited by this paper
• Isolation of tissue‐type plasminogen activator, cathepsin H, and non‐specific cross‐reacting antigen from SK‐PC‐1 pancreas cancer cells using subtractive hybridization

  1996cited by this paper
• Transient translational silencing by reversible mRNA deadenylation.

  1992cited by this paper
• Plasminogen activator dependent pathways in the dissemination of human tumor cells in the chick embryo.

  1988cited by this paper
• Meiotic maturation of mouse oocytes triggers the translation and polyadenylation of dormant tissue-type plasminogen activator mRNA.

  1987cited by this paper
• Plasminogen activator in mouse and rat oocytes: induction during meiotic maturation.

  1985cited by this paper
• Behavior of transforming growth factors in serum-free media: An improved assay for transforming growth factors

  1984cited by this paper
• THE CHICK EMBRYO

  1965cited by this paper

• RNA-Binding Proteins in Adipose Biology: From Mechanistic Understanding to Therapeutic Opportunities

  2026cites this paper
• RNA binding protein DDX3X drives pancreatic cancer progression via the TLE2-MYL9 axis

  2025cites this paper
• Cytoplasmic regulation of the poly(A) tail length as a potential therapeutic target

  2025cites this paper
• Regulatory Functions of TDP‐43 and FMRP in Non‐Neuronal Diseases: Are Co‐Targeted mRNAs the Keys?

  2025cites this paper
• Molecular network analysis of CPEB4 translational control and targeting CPEB4/β-catenin to modulate invasion and migration of nasopharyngeal carcinoma cells

  2025cites this paper
• The dual role of RNA-binding proteins: promotion of tumorigenesis, drug resistance, and emerging therapeutic targets

  2025cites this paper
• Visfatin (NAMPT) affects global gene expression in porcine anterior pituitary cells during the mid-luteal phase of the oestrous cycle

  2024cites this paper
• Poly(A) tale: From A to A; RNA polyadenylation in prokaryotes and eukaryotes

  2024cites this paper
• The RNA‐binding protein sorbin and SH3 domain‐containing 2 are transcriptionally regulated by specificity protein 1 and function as tumor suppressors in bladder cancer by stabilizing tissue factor pathway inhibitor

  2024cites this paper
• CPEB4 modulates liver cancer progression by translationally regulating hepcidin expression and sensitivity to ferroptosis

  2024cites this paper
• Validation of ZIP4 as a tumour-associated antigen for nanotargeting

  2024cites this paper
• CYP24A1, AHR, CPEB4, TRIP13, and PIK3CA genes expression in colorectal cancer patients: novel diagnostic biomarkers.

  2023cites this paper
• Antitumor T‐cell function requires CPEB4‐mediated adaptation to chronic endoplasmic reticulum stress

  2023cites this paper
• The P-body protein 4E-T represses translation to regulate the balance between cell genesis and establishment of the postnatal NSC pool.

  2023cites this paper
• Identification of novel genes associated with exercise and calorie restriction effects in skeletal muscle

  2023cites this paper
• Role of the RNA-binding protein family in gynecologic cancers.

  2023cites this paper
• miRNA-130a-3p/CPEB4 Axis Modulates Glioblastoma Growth and Progression

  2023cites this paper
• RNA-binding proteins in ovarian cancer: a novel avenue of their roles in diagnosis and treatment

  2022cites this paper
• mTOR- and LARP1-dependent regulation of TOP mRNA poly(A) tail and ribosome loading.

  2022cites this paper
• RNA Binding Proteins (RBPs) and their role in DNA Damage and radiation response in cancer.

  2022cites this paper
• Pathogenic mis-splicing of CPEB4 in schizophrenia

  2022cites this paper
• Control of immediate early gene expression by CPEB4-repressor complex-mediated mRNA degradation

  2022influential citation
• The Role of RNA-Binding Proteins in Hematological Malignancies

  2022cites this paper
• CircESRP1 enhances metastasis and epithelial–mesenchymal transition in endometrial cancer via the miR-874-3p/CPEB4 axis

  2022cites this paper
• Protein synthesis control in cancer: selectivity and therapeutic targeting

  2022cites this paper
• Immune translational control by CPEB4 regulates intestinal inflammation resolution and colorectal cancer development

  2022cites this paper
• System Biology-Guided Chemical Proteomics to Discover Protein Targets of Monoethylhexyl Phthalate in Regulating Cell Cycle.

  2021cites this paper
• Development and Validation of Ten-RNA Binding Protein Signature Predicts Overall Survival in Osteosarcoma

  2021cites this paper
• CPEB4-Promoted Paclitaxel Resistance in Ovarian Cancer In Vitro Relies on Translational Regulation of CSAG2

  2021influential citation
• Transcriptome Analyses Identify an RNA Binding Protein Related Prognostic Model for Clear Cell Renal Cell Carcinoma

  2021cites this paper
• CPEB4 Inhibit Cell Proliferation via Upregulating p21 mRNA Stability in Renal Cell Carcinoma

  2021cites this paper
• Translational Control in Liver Disease

  2021cites this paper
• Targeting the cytoplasmic polyadenylation element-binding protein CPEB4 protects against diet-induced obesity and microbiome dysbiosis

  2021cites this paper
• CPEB alteration and aberrant transcriptome-polyadenylation lead to a treatable SLC19A3 deficiency in Huntington’s disease

  2021cites this paper
• Sex-specific genetic factors affect the risk of early-onset periodontitis in Europeans.

  2021cites this paper
• Identification of dynamic RNA-binding proteins uncovers a Cpeb4-controlled regulatory cascade during pathological cell growth of cardiomyocytes.

  2021cites this paper
• The role of CPEB family proteins in the nervous system function in the norm and pathology

  2021cites this paper
• Identification of Prognosis-related Hub RNA Binding Proteins Function through Regulating Metabolic Processes in Tongue Cancer

  2021cites this paper
• Molecular response to PARP1 inhibition in ovarian cancer cells as determined by mass spectrometry based proteomics

  2021cites this paper
• LncRNA RP11-361F15.2 promotes osteosarcoma tumorigenesis by inhibiting M2-Like Polarization of Tumor-Associated Macrophages of CPEB4.

  2020cites this paper
• Single‐cell RNA sequencing reveals chemokine self‐feeding of myeloma cells promotes extramedullary metastasis

  2020cites this paper
• Investigation of the expression levels of CPEB4, APC, TRIP13, EIF2S3, EIF4A1, IFNg, PIK3CA and CTNNB1 genes in different stage colorectal tumors

  2020cites this paper
• CPEB3 functions as a tumor suppressor in colorectal cancer via JAK/STAT signaling

  2020cites this paper
• Crosstalk Between Angiogenesis and Fibrogenesis in Liver Disease

  2020cites this paper
• CPEB3-mediated MTDH mRNA translational suppression restrains hepatocellular carcinoma progression

  2020cites this paper
• RNA-Binding Proteins in Cancer: Functional and Therapeutic Perspectives

  2020cites this paper
• RNA-binding proteins in tumor progression

  2020cites this paper
• LncRNA EWSAT1 upregulates CPEB4 via miR-330-5p to promote cervical cancer development

  2020cites this paper
• The RNA-binding protein Cpeb4 is a novel positive regulator of osteoclast differentiation.

  2020cites this paper
• HuR/ELAVL1 drives malignant peripheral nerve sheath tumor growth and metastasis

  2020cites this paper
• The Role of Translation Control in Tumorigenesis and Its Therapeutic Implications

  2020cites this paper
• CPEB4 Increases Expression of PFKFB3 to Induce Glycolysis and Activate Mouse and Human Hepatic Stellate Cells, Promoting Liver Fibrosis.

  2020cites this paper
• CPEB1 or CPEB4 knockdown suppresses the TAK1 and Smad signalings in THP-1 macrophage-like cells and dermal fibroblasts.

  2020cites this paper
• A meta-analysis of multiple matched aCGH/expression cancer datasets reveals regulatory relationships and pathway enrichment of potential oncogenes

  2019cites this paper
• Characterization of Muscle Glycogen Synthase and its Association with RNA in Sertoli Cells

  2019cites this paper
• Pericytes in the Gut.

  2019cites this paper
• RNA Binding Protein Networks and Translational Regulation in Oocytes

  2019cites this paper
• Les Spreading Initiations Centers et la traduction locale régulent l'adhésion et l'étalement des cellules mésenchymateuses

  2019cites this paper
• Tumor suppressor role of cytoplasmic polyadenylation element binding protein 2 (CPEB2) in human mammary epithelial cells

  2019cites this paper
• Cancer The 'RBP'eutics - RNA-Binding Proteins as Therapeutic Targets for Cancer.

  2019cites this paper
• CPEB4 regulates glioblastoma cell proliferation and predicts poor outcome of patients.

  2018cites this paper
• Knockdown of CPEB4 expression suppresses cell migration and invasion via Akt pathway in non‐small cell lung cancer

  2018influential citation
• Probing new interaction partners for cop-per chaperones

  2018cites this paper
• CPEB2‐dependent translation of long 3′‐UTR Ucp1 mRNA promotes thermogenesis in brown adipose tissue

  2018cites this paper
• Contrôle traductionnel des fonctions des macrophages par les répresseurs 4E-BP1 et 4E-BP2

  2018cites this paper
• CPEB4 promotes growth and metastasis of gastric cancer cells via ZEB1-mediated epithelial– mesenchymal transition

  2018cites this paper
• Trans‐acting translational regulatory RNA binding proteins

  2018influential citation
• Cpeb2 in mammary gland homeòstasis and breast cancer

  2018influential citation
• Commentary on “Association of mir12475p Expression with Clinicopathological Parameters and Prognosis in Breast Cancer”

  2018cites this paper
• Tumor cell-targeted delivery of CRISPR/Cas9 by aptamer-functionalized lipopolymer for therapeutic genome editing of VEGFA in osteosarcoma.

  2017cites this paper
• Translational Dysregulation in Cancer: Molecular Insights and Potential Clinical Applications in Biomarker Development

  2017cites this paper
• RNA-Binding Proteins in Cancer: Old Players and New Actors.

  2017cites this paper
• Oncogenic Activation of the RNA Binding Protein NELFE and MYC Signaling in Hepatocellular Carcinoma.

  2017cites this paper
• MicroRNA-29c-5p suppresses gallbladder carcinoma progression by directly targeting CPEB4 and inhibiting the MAPK pathway

  2017cites this paper
• Translational reprogramming in tumour cells can generate oncoselectivity in viral therapies

  2017cites this paper
• Roles of Copper-Binding Proteins in Breast Cancer

  2017cites this paper
• Defining the human copper proteome and analysis of its expression variation in cancers.

  2017cites this paper
• Gene isoforms as expression-based biomarkers predictive of drug response in vitro

  2017cites this paper
• Circadian- and UPR-dependent control of CPEB4 mediates a translational response to counteract hepatic steatosis under ER stress

  2017cites this paper
• Identification of miRNA and genes involving in osteosarcoma by comprehensive analysis of microRNA and copy number variation data

  2017cites this paper
• Overexpression of CPEB4 in glioma indicates a poor prognosis by promoting cell migration and invasion

  2017cites this paper
• Genetic dissection of the planarian reproductive system through characterization of Schmidtea mediterranea CPEB homologs

  2017cites this paper
• Olfactory-Experience- and Developmental-Stage-Dependent Control of CPEB4 Regulates c-Fos mRNA Translation for Granule Cell Survival.

  2017cites this paper
• Retraction Note: The microRNA-1246 promotes metastasis in non-small cell lung cancer by targeting cytoplasmic polyadenylation element-binding protein

  2017cites this paper
• The Role of Cytoplasmic Polyadenylation Element Binding Protein -2 (CPEB-2) in Human Breast Cancer

  2017cites this paper
• Combined analysis of genome sequencing and RNA-motifs reveals novel damaging non-coding mutations in human tumors

  2017cites this paper
• Characterization of novel RNA-binding proteins in cancer

  2017cites this paper
• CPEB4 and IRF4 expression in peripheral mononuclear cells are potential prognostic factors for advanced lung cancer.

  2017cites this paper
• Downregulated cytoplasmic polyadenylation element-binding protein-4 is associated with the carcinogenesis of head and neck squamous cell carcinoma.

  2017cites this paper
• Knockdown of CPEB 4 expression suppresses cell migration and invasion via Akt pathway in non-small cell lung cancer † Running Head : Knockdown of CPEB 4 suppresses cell migration and invasion in NSCLC

  2017cites this paper
• MicroRNA-29c-5p suppresses gallbladder carcinoma progression by directly targeting CPEB4 and inhibiting the MAPK pathway

  2017cites this paper
• Somatic CPEB4 and CPEB1 genes mutations spectrum on the prognostic predictive accuracy in patients with high-grade glioma and their clinical significance.

  2016cites this paper
• Extended functional repertoire for human copper chaperones

  2016cites this paper
• Sequential Functions of CPEB1 and CPEB4 Regulate Pathologic Expression of Vascular Endothelial Growth Factor and Angiogenesis in Chronic Liver Disease.

  2016cites this paper
• High expression of cytoplasmic polyadenylation element-binding protein 4 correlates with poor prognosis of patients with colorectal cancer

  2016cites this paper
• CPEB4 interacts with Vimentin and involves in progressive features and poor prognosis of patients with astrocytic tumors

  2016cites this paper
• Regulation of the Expression of Cytoplasmic Polyadenylation Element Binding Proteins for the Treatment of Cancer.

  2016cites this paper
• MYC in pancreatic cancer: novel mechanistic insights and their translation into therapeutic strategies

  2016cites this paper
• Cytoplasmic polyadenylation element-binding protein 4 is highly expressed in human glioma

  2016cites this paper
• Altered splicing leads to reduced activation of CPEB3 in high-grade gliomas

  2016cites this paper